Sandoz is a global leader in the production of high quality generic medicines. We help improve lives by developing, producing and distributing high quality, affordable pharmaceuticals. Thanks to our global network, Sandoz medicines are available to 90% of the world’s population. In addition to direct cost savings to patients, we contribute to the stability of healthcare systems and free up resources for new and innovative medicines.
Sandoz makes far more than just traditional off-patent medicines. We stand out from the crowd thanks to our ability to develop and produce a wide range of difficult-to-make medicines, from complex delivery systems for standard generics through to modern biopharmaceutical medicines (biosimilars).
In Australia, we utilise our global platform of resources and expertise to bring products to market that reflect not only cost advantages, but also the high quality standards demanded by pharmacists, patients and the Australian healthcare industry.
All of our products go through years of rigorous testing and quality control and in many cases, have already been marketed by Sandoz in other countries. As a result, once we receive approval from the Therapeutic Goods Administration (TGA) to market our medicines in Australia they may have already have been marketed in other countries for considerable lengths of time. This supports the quality and efficacy of our range as well as the trust healthcare practitioners place in our products, the world over.
a Novartis company
Sandoz is a Novartis company, a world leader in developing medicines to protect health, cure disease and improve wellbeing. As a Novartis company, a major global innovator, Sandoz directly contributes to the research and development of new and innovative medicines, securing the promise of improving future health outcomes.
Click here to learn more about Novartis and the goal to discover, develop and successfully market innovative products to treat patients, ease suffering and to enhance quality of life.